,6,7,8,9 Highly effective triple combination drugs are now available for more than 90% of people with CF who have one or two copies of the F508del allele, leaving approximately 10% of patients with no treatment options, such as those with CFTR nonsense and splice site mutations. Here, CFTR is linked to cystic fibrosis.